Implication for health policy/practice/research/medical education: Antiphospholipid syndrome (APS) is being increasingly recognized as an important cause of kidney injury due to thrombosis at any location within the renal vasculature. The term antiphospholipid syndrome nephropathy (APSN) refers to the kidney damage caused by vascular lesions in the glomeruli, arterioles and/ or interlobular arteries in patients with antiphospholipid antibodies. APSN manifests with hypertension, acute and/or chronic kidney failure, and often a lowgrade proteinuria.
No takes yet. Share an insight, caveat, or question.
Hamid Nasri (2012) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: